As other groups and we have proposed NCS1 as a pharmacological target for treating various neurological diseases, particularly neurodevelopmental and psychiatric diseases16,19,25–30, future studies will also benefit from considering potential sex-specific differences in NCS1 functions. The gene discussed is NCS1; the disease is nervous system disorder.